Before joining the New York Angels, you should make sure that our investment criteria and process are in alignment with your expectations. 

As an aggregate, the members of New York Angels invest between $100,000 and $1,000,000 per round in early stage companies. Our members are 
looking for companies that have an established proof of concept and are poised for growth. Members have invested across multiple industries but have a core strength in business products & services, digital media, financial services, healthtech, and medical devices. 

Portfolio company pre-money valuations for New York Angels' seed rounds of investment typically range from $2,500,000 to $6,000,000, with preferred equity being the typical investment structure. Our sample term sheet can be found at 

Management team
We look for teams of high-quality entrepreneurs
with a track record of leadership and performance
- either in the company's specific industry or in
prior entrepreneurial ventures. We also look at
the team's passion for and commitment to the
As we will be working together as partners, the team's credibility is essential. In addition, the team must be open to and comfortable with receiving input provided by angel investors.

Market opportunity
We invest in solutions that address major problems for significantly large addressable target markets (i.e. a $500+ million market). The company must demonstrate a strategy to claim a reasonable share of this market. 




Most New York Angels deals have pre-money valuations that are between $2.5 million and $6 million. A key reason for this range is that it gives the investor the potential for a nice return at a modest exit valuation. It also allows for some protection against future round dilution. It is in the entrepreneur’s best interest to have the valuations of subsequent rounds increasing and avoiding bad will and anti-dilution ratchets.


Use of proceeds
Funds must be used to accelerate the company's achievement of key milestones that increase the company's value. We often fund activities that
include research and product development,
building a sales and marketing infrastructure
and hiring key executives.


Growth potential


Competitive advantage
The company must have some proprietary
features that distinguish it from potential
competitors or provide barriers to entry that
prevent other companies from capturing
and skills), and access to scarce raw materials.




rather than incremental enhancements to
common products and services. Is this a nice-to-
Further, we avoid science projects that don't demonstrate a clear path to commercialization.
Any breakthrough innovation must be
accompanied by a strong business plan.


Exit strategy